Whether or not the ACH-3422 monotherapy data are presented at AASLD isn't the point; rather, the point is that the release of the ACH-3422 mono data is not a pivotal event for the HCV arena.
Lots of HCV nukes have shown impressive monotherapy data and ended up failing, as has been discussed ad naueam.
News 
Market Data 
Discover 
